Reciprocal relationship from DNTH graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from DNTH graph: tents Cash Flows from Financing Activities For the year ended December 31, …
Reciprocal relationship from VKTX graph: from non-elective hip fracture surgery. However, VK5211, if approved, will face competition from experimental therapies that are in various stages of clinical…
Reciprocal relationship from DNTH graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from DNTH graph: tents Cash Flows from Financing Activities For the year ended December 31, …
Reciprocal relationship from VKTX graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from VKTX graph: Reciprocal relationship from LGNZZ graph: Reciprocal relationship from VKTX…
LIGAND PHARMACEUTICALS INC Debt Obligations
Instrument
Description
Confidence
Evidence
LGNZZ-DEBT-10695
Warrants outstanding: 3264643
90%
xbrl warrant detail from xbrl 2023-12-31.
LGNZZ-DEBT-10696
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
LIGAND PHARMACEUTICALS INC Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for LIGAND PHARMACEUTICALS INC.
LIGAND PHARMACEUTICALS INC Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for LIGAND PHARMACEUTICALS INC.